The defective step distinguishes the disorders
GeneReviews describes GAMT and AGAT deficiencies as disorders of creatine synthesis and SLC6A8-related deficiency as a transport disorder. Developmental delay, cognitive impairment and speech-language difficulties are common features, while other manifestations vary. [1]
These conditions are not interchangeable. A defect in making creatine and a defect in moving it into cells present different treatment challenges. [1]
Diagnosis and treatment require specialist evaluation
The review describes genetic testing alongside suggestive clinical findings. A person’s nonspecific fatigue or response to a retail creatine product cannot establish one of these diagnoses. [1]
Management depends on the identified disorder and may include carefully supervised nutritional treatment and ongoing neurological and biochemical assessment. A sports-supplement serving is not a replacement for that clinical plan. [1]
The same word can hide different mechanisms
Imagine two patients have low cerebral creatine but different underlying defects. One has impaired synthesis and the other impaired transport. The shared word deficiency does not establish that an identical intervention will work equally well.
| Detail | Interpretation |
|---|---|
| GAMT / AGAT | Synthesis disorders |
| SLC6A8 | Transport disorder |
| Training fatigue | Not diagnostic |
Sources for this article
- Creatine Deficiency Disorders - GeneReviews® - NCBI Bookshelf
Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.